Is 22% suppression of DHEA‑S after an overnight dexamethasone suppression test considered partial or inadequate suppression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

22% DHEA-S Suppression is Inadequate

A 22% suppression of DHEA-S after an overnight dexamethasone suppression test is considered inadequate suppression. According to the American Association of Clinical Endocrinologists guidelines, adequate suppression of DHEA-S requires greater than 60% reduction from baseline to indicate adrenal origin of androgens 1.

Interpretation Framework for Dexamethasone Suppression Testing

DHEA-S Suppression Thresholds

The AACE guidelines establish clear cutoff values for interpreting dexamethasone suppression tests in hyperandrogenic disorders:

  • Adequate DHEA-S suppression: >60% reduction from baseline
  • Adequate testosterone suppression: >40% reduction from baseline

With only 22% suppression of DHEA-S, this result falls far below the 60% threshold needed to demonstrate adrenal responsiveness to dexamethasone 1.

Clinical Significance of Inadequate Suppression

This inadequate suppression pattern suggests one of three possibilities:

  1. Primary ovarian source of androgens - If DHEA-S shows inadequate suppression (<60%) but cortisol suppresses normally, the androgen excess likely originates from the ovaries rather than the adrenal glands 1

  2. Combined ovarian and adrenal contribution - Partial suppression of DHEA-S (between 0-60%) typically indicates both ovarian and adrenal sources are contributing to the hyperandrogenism 1

  3. Adrenal hyperfunction or non-compliance - If inadequate DHEA-S suppression occurs alongside failure of cortisol suppression, this raises concern for adrenal pathology (Cushing's syndrome, adrenal tumor) or patient non-adherence to the dexamethasone protocol 1

Important Caveats

Verify cortisol suppression status: The interpretation of inadequate DHEA-S suppression must be contextualized with the cortisol response. If cortisol appropriately suppressed but DHEA-S did not, this points toward ovarian androgen production. If neither suppressed adequately, adrenal pathology becomes more likely 1.

Consider patient compliance: Inadequate suppression can result from failure to take dexamethasone as directed. Measuring dexamethasone levels simultaneously can help distinguish true inadequate suppression from non-compliance 2, 3.

Assess for interfering medications: CYP3A4 inducers (phenobarbital, carbamazepine, rifampin) can accelerate dexamethasone metabolism, leading to falsely inadequate suppression 2, 4.

Next Steps After Inadequate Suppression

When DHEA-S suppression is inadequate at 22%:

  • Confirm the result by repeating the test or performing a 2-day dexamethasone suppression test for more comprehensive evaluation 1
  • Measure testosterone suppression to determine if there is a combined ovarian-adrenal contribution (testosterone <40% suppression suggests combined source) 1
  • Consider GnRH stimulation testing if ovarian source is suspected, to confirm ovarian origin of excess androgens 1
  • Evaluate for adrenal pathology if cortisol also fails to suppress, including imaging and consideration of Cushing's syndrome workup 1

References

Guideline

american association of clinical endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2001

Guideline

the diagnosis of cushing's syndrome: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.